BNTX - BioNTech launches new $0.5B ADS repurchase program
2023-03-28 06:54:04 ET
- BioNTech SE ( NASDAQ: BNTX ) has approved to new buyback program to repurchase up to $0.5B of American Depositary Shares, each representing one ordinary share, of the company during the remainder of 2023.
- The drug maker expects to use all or a portion of the repurchased ADSs and the ADSs held in treasury to satisfy upcoming settlement obligations under the company’s share-based payment arrangements.
- The share repurchase program announced on March 31, 2022 of up to $1.5B concluded on March 17, 2023 with a total repurchase amount of $1.3B.
- Shares are marginally down in Tuesday's premarket hours.
For further details see:
BioNTech launches new $0.5B ADS repurchase program